Your browser doesn't support javascript.
loading
Phase I study of bortezomib in refractory or relapsed acute leukemias.
Cortes, Jorge; Thomas, Deborah; Koller, Charles; Giles, Francis; Estey, Elihu; Faderl, Stefan; Garcia-Manero, Guillermo; McConkey, David; Ruiz, Stacey L; Patel, Gira; Guerciolini, Roberto; Wright, John; Kantarjian, Hagop.
Affiliation
  • Cortes J; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. jcortes@mdanderson.org
Clin Cancer Res ; 10(10): 3371-6, 2004 May 15.
Article in En | MEDLINE | ID: mdl-15161691
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Myelodysplastic Syndromes / Boronic Acids / Leukemia, Myeloid, Acute / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2004 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Myelodysplastic Syndromes / Boronic Acids / Leukemia, Myeloid, Acute / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2004 Document type: Article Affiliation country: United States Country of publication: United States